FDA clears new uses for Aragon Surgical's laparascopic device
Aragon Surgical, a Palo Alto, Calif., medical-devices maker, said the FDA cleared its LapCap product for use in general surgery. Aragon, which doesn’t seem to have a Web site, gained ownership of the LapCap when it acquired VeriSure, another device maker, in March.
The LapCap is designed to ease the initial steps of minimally invasive, or laparoscopic, surgery, in which surgeons must pass a needle into the abdomen in order to blow in gas that will expand the abdominal cavity. The LapCap guides this needle into the proper location, helping to avoid inadvertent needle-related injuries. The device was previously only cleared for use in gynecologic laparoscopies.
Aragon is backed by Delphi Ventures and Onset Ventures.
Next Story: TheraGenetics raises $6M for personalized medicine
Previous Story: Social network scramble: Facebook, Google and Yahoo
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.
